NovoDETECT® was established to facilitate access to testing for patients, in line with our commitment to drive comprehensive, affordable patient access and our goal to simplify the complex US healthcare system for patients.
NovoDETECT® is Novo Nordisk’s commitment to support people living with chronic disease access diagnostic services. NovoDETECT® aims to reduce barriers to diagnosis for people living with liver disease and recurrent kidney stones.